Reach Us +44-1522440391
Hideaki Ogata | OMICS International
ISSN: 2167-7700

Chemotherapy: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Hideaki Ogata

Toho University School of Medicine, 6-11-1 Omorinishi, Ota-ku, Tokyo 143-8541

Antiangiogenic Therapy Combined with Chemotherapy Including Platinum Agents as a Therapeutic Option for Triple Negative Breast Cancer

Triple negative breast cancer (TNBC) is an aggressive histological subtype with limited treatment options. While rationally-derived regimens are emerging from the results of recent gene profiling studies, TNBC is an angiogenesis-dependent malignancy, and antiangiogenic therapies have been examined energetically in this field. Antiangiogenic agents ... Read More»

Hideaki Ogata, Makoto Sumazaki and Fumi Saito

Brief Report: Chemotherapy (Los Angel) 2018, 7: 255

DOI: 10.4172/2167-7700.1000255

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article